Intratumoral expression
|
---|
| |
PD-L2
|
CD3
|
CD8
|
FOXP3
|
---|
|
N
|
Low (0–1)
|
High (2–3)
|
P
|
Low
|
High
|
P
|
Low
|
High
|
P
|
Low
|
High
|
P
|
Sex
|
Male
|
158
|
125
|
33
|
0.540
|
113
|
45
|
0.805
|
129
|
29
|
0.066
|
131
|
27
|
0.502
|
Female
|
147
|
112
|
35
| |
107
|
40
| |
131
|
16
| |
126
|
21
| |
Age
|
< 60
|
106
|
86
|
20
|
0.340
|
76
|
30
|
0.138
|
86
|
20
|
0.139
|
88
|
18
|
0.663
|
≥60
|
199
|
152
|
47
| |
144
|
55
| |
174
|
25
| |
169
|
30
| |
Location
|
Head
|
181
|
136
|
45
|
0.348
|
130
|
51
|
0.913
|
153
|
28
|
0.885
|
147
|
34
|
0.030
|
Body
|
62
|
49
|
13
| |
44
|
18
| |
53
|
9
| |
59
|
3
| |
Tail
|
62
|
52
|
10
| |
46
|
16
| |
54
|
8
| |
51
|
11
| |
Grade
|
Well
|
16
|
14
|
2
|
0.361
|
10
|
6
|
0.677
|
14
|
2
|
0.908
|
13
|
3
|
0.941
|
Moderate
|
175
|
140
|
35
| |
127
|
48
| |
150
|
25
| |
148
|
27
| |
Low
|
114
|
85
|
29
| |
83
|
31
| |
96
|
18
| |
96
|
18
| |
Tumor stage
|
T1
|
51
|
43
|
8
|
0.494
|
33
|
18
|
0.252
|
40
|
11
|
0.212
|
45
|
6
|
0.694
|
T2
|
176
|
135
|
41
| |
133
|
43
| |
149
|
27
| |
147
|
29
| |
T3
|
78
|
60
|
18
| |
54
|
24
| |
70
|
8
| |
65
|
13
| |
Node stage
|
N0
|
154
|
125
|
29
|
0.020
|
109
|
45
|
0.343
|
137
|
17
|
0.007
|
133
|
21
|
0.562
|
N1
|
108
|
79
|
29
| |
76
|
32
| |
83
|
25
| |
88
|
20
| |
N2
|
43
|
40
|
3
| |
35
|
8
| |
35
|
8
| |
36
|
7
| |
AJCC stage
|
I
|
124
|
103
|
21
|
0.154
|
90
|
34
|
0.274
|
109
|
15
|
0.071
|
108
|
16
|
0.509
|
II
|
138
|
101
|
37
| |
95
|
43
| |
111
|
27
| |
113
|
25
| |
III
|
43
|
34
|
9
| |
35
|
8
| |
40
|
3
| |
36
|
7
| |
- TILs tumor infiltrating lymphocytes, PDAC pancreatic ductal adenocarcinoma